Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analysis of venous thromboembolism identifies new risk loci and genetic overlap with arterial vascular disease.
|
31676865 |
2019 |
Venous Thromboembolism
|
0.200 |
Biomarker
|
phenotype |
BEFREE |
ABO blood group influences risk of venous thromboembolism and myocardial infarction.
|
31820263 |
2019 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
Genomic and transcriptomic association studies identify 16 novel susceptibility loci for venous thromboembolism.
|
31420334 |
2019 |
Venous Thromboembolism
|
0.200 |
Biomarker
|
phenotype |
BEFREE |
ABO blood type and RBC transfusion were found to be independent risk factors for pregnancy-associated VTE.
|
31537816 |
2019 |
Venous Thromboembolism
|
0.200 |
Biomarker
|
phenotype |
BEFREE |
Validating the role of ABO blood type in risk of perioperative venous thromboembolism after radical cystectomy.
|
29876671 |
2019 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
A genetic risk score combining the VTE-associated FGG and ABO alleles improved the risk prediction of VTE.
|
29995659 |
2018 |
Venous Thromboembolism
|
0.200 |
AlteredExpression
|
phenotype |
BEFREE |
This review summarizes the epidemiology VTE in CKD and reviews the biochemistry of factor VIII and determinants of its levels, including von Willebrand factor and ABO blood group.
|
30081388 |
2018 |
Venous Thromboembolism
|
0.200 |
Biomarker
|
phenotype |
BEFREE |
Patient's ABO blood group should be considered in terms of risk stratification and selection of appropriate postoperative VTE prophylaxis.
|
28366316 |
2017 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
ABO blood groups and risk of deep venous thromboembolism in Chinese Han population from Chaoshan region in South China.
|
28397946 |
2017 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
ABO blood types associated with the risk of venous thromboembolism in Han Chinese people: A hospital-based study of 200,000 patients.
|
28262729 |
2017 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
|
28373160 |
2017 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis.
|
26908601 |
2016 |
Venous Thromboembolism
|
0.200 |
Biomarker
|
phenotype |
BEFREE |
In conclusion, this study confirms the influence of smoking and obesity and shows for the first time the impact of ABO blood group on the risk of VTE in women under COC.
|
26290123 |
2016 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
Among the genome-wide significant results, our study replicated previously known venous thromboembolism (VTE) loci near the F5, FGA-FGG, F11, F2, PROCR and ABO genes, and the more recently discovered locus near SLC44A2 In addition, our study reports for the first time a genome-wide significant association between rs114209171, located upstream of the F8 structural gene, and thrombosis risk.
|
26908601 |
2016 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
Nine loci reached the genome-wide significance level of 5 × 10(-8) including six already known to associate with VTE (ABO, F2, F5, F11, FGG, and PROCR) and three unsuspected loci.
|
25772935 |
2015 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism.
|
25772935 |
2015 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.
|
23650146 |
2013 |
Venous Thromboembolism
|
0.200 |
Biomarker
|
phenotype |
BEFREE |
The role of ABO blood type as a risk factor for recurrent venous thromboembolism (VTE) in patients with a first unprovoked VTE who complete oral anticoagulation therapy is unknown.
|
24067945 |
2013 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
In conclusion, this large GWAS replicated key genetic associations in F5 and ABO, and confirmed the importance of F11 and FGG loci for VTE.
|
23650146 |
2013 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide association study for venous thromboembolism: the extended cohorts for heart and aging research in genomic epidemiology (CHARGE) consortium.
|
23650146 |
2013 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
|
22672568 |
2012 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
To evaluate the possible clinical implication of the different ABO blood groups on the risk of developing venous thromboembolism (VTE), we conducted a meta-analysis of the existing literature.
|
22740183 |
2012 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
BEFREE |
ABO re-sequencing identified 15 novel single nucleotide variations (SNV) in ABO intron 6 and the ABO 3' UTR that were strongly associated with VTE (P<10(-4)) and belonged to three distinct linkage disequilibrium (LD) blocks; none were in LD with ABO rs8176719 or rs2519093.
|
22672568 |
2012 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASDB |
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
|
22672568 |
2012 |
Venous Thromboembolism
|
0.200 |
GeneticVariation
|
phenotype |
GWASCAT |
Genetics of venous thrombosis: insights from a new genome wide association study.
|
21980494 |
2011 |